Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

4

Revenue 2017

Sanofi

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Sanofi's 2013 sales performance.

Sanofi

Sanofi reveals $330m collaboration with Blackstone Life Sciences

Sanofi reveals $330m collaboration with Blackstone Life Sciences According to the terms of the deal, Sanofi will continue to fully manage the clinical programme, retaining full rights and control of Sarclisa. ... With the aim of offering a more patient-centric treatment experience, Sanofi has partnered with Enable

Sanofi experiences setback in phase 2 breast cancer trial

Sanofi experiences setback in phase 2 breast cancer trial Sanofi has announced that one of its top pipeline therapies, a selective oestrogen receptor degrader (SERD) amcenestrant, failed to meet its primary endpoint of improving progression-free survival. ... While results from the clinical trial showed that it

2022 PM Society Awards

2022 PM Society Awards Other client Gold winners were Allergan Aesthetics, an AbbVie Company, Campaign Against Living Miserably (CALM), Fresenius Kabi, Greenwich BioSciences, Mölnlycke, Novo Nordisk, Roche/Chugai, Sanofi Genzyme and ViiV Healthcare.

Sanofi and Regeneron announce positive phase 3 trial results for Dupixent

Sanofi and Regeneron announce positive phase 3 trial results for Dupixent Sanofi and Regeneron Pharmaceuticals have announced positive results from a second phase 3 trial, showing Dupixent (dupilumab) – when administered in 300mg doses weekly – significantly improved the signs and symptoms of eosinophilic

FDA accepts Priority Review for Dupixent in children with moderate-to-severe atopic dermatitis

FDA accepts Priority Review for Dupixent in children with moderate-to-severe atopic dermatitis If approved, Dupixent – developed by Regeneron Pharmaceuticals and Sanofi Genzyme – would be used as a supplementary treatment for managing moderate-to-severe atopic dermatitis and is aimed at children whose condition

[ Previous 5 results ] 3 4 5 6 7 8 9 10 11 12 [ Next 5 results ]

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Oncosec

OncoSec is a clinical-stage biotechnology company focused on developing cytokine-based intratumoral immunotherapies to stimulate the body's immune system to target...

Latest intelligence

KOL Ambassador Program & Podcast Creation: A Customer Story
...
Animation: Living With
The journey from the patient's perspective...
Danny Buckland July2022
Achieving communication excellence by targeting the right channel at the right time
By Danny Buckland...